经鼻蝶神经内镜与显微镜下切除垂体瘤的安全性与疗效对比

doi:10.19854/j.cnki.1008-2425.2022.01.0003

摘要/Abstract

摘要： 目的比较经鼻蝶神经内镜与显微镜下切除垂体瘤的安全性和疗效。方法回顾性分析我院自2019年7月至2021年8月垂体瘤患者391例,其中神经内镜组212例,显微镜组179例,对比两组患者的手术时间、术中出血量、住院时间、肿瘤全切率、术中脑脊液漏的发生率、术后并发症的发生情况、术后视力视野的改善情况以及相关的围手术期指标。结果同显微镜组相比,神经内镜组患者手术时间明显较长(129.66±49.66 mins vs.76.87±19.23 mins,P＜0.001),两组患者总体肿瘤全切率无明显异常(70.8% vs.63.7%,P=0.137),但其中Knosp III-IV级的患者,神经内镜组的手术全切率有明显优势(67.1% vs.32.3%,P＜0.001)。两组患者在术中出血量(67.33±19.95mL vs.62.21±15.45mL,P=0.082)、术后住院时间(4.65±1.31天 vs.4.31±1.24天,P=0.237)、术中高流量脑脊液漏的发生率(4.7% vs.6.1%,P=0.533)、术中颈内动脉损伤情况(0.5% vs.0.6%, P=0.904)和术后垂体相关激素水平的恢复等指标上均无统计学差异。两组患者的术后并发症的发生率均很低,且两组患者之间无统计学差异,包括:术后脑脊液鼻漏(0.9% vs.1.6%,P=0.558)、颅内感染(0.9% vs.1.1%,P=0.865)、尿崩(4.2% vs.6.1%,P=0.533)、再出血(0.9% vs.1.1%,P=0.865)。两组患者术后的视力视野较术前均明显好转,但两组患者之间的好转率无显著差异(77.9% vs.85.7%,P=0.170)。结论经鼻蝶神经内镜与显微镜下切除垂体瘤均具有满意的安全性与疗效,对于Knosp III-IV级肿瘤侵犯海绵窦的患者,神经内镜手术更具优势。

关键词: 神经内镜, 显微镜, 经鼻蝶手术, 垂体瘤

Abstract: Objective To compare the safety and efficacy of transsphenoidal neuroendoscopic and microscopical resection of pituitary tumors.Methods 391 cases of pituitary tumor in our hospital from July 2019 to August 2021 were retrospectively analyzed,including 212 cases in the neuroendoscopy group and 179 cases in the microscope group.Operation time,intraoperative blood loss,length of stay,the rate of total removal of tumor,incidence of intraoperative cerebrospinal fluid leakage,occurrence of postoperative complications,improvement of postoperative visual field and related perioperative indicators were compared between the two groups.Results Compared with the microscope group,the operation time of patients in the neuroendoscopy group was significantly longer (129.66±49.66mins vs.76.87± 19.23mins,P< 0.001),and the total tumor resection rate in the two groups was not significantly abnormal (70.8% vs.63.7%,P=0.137).However,for Knosp III-IV patients,the total surgical resection rate was significantly higher in the neuroendoscopic group (67.1% vs.32.3%,P< 0.001).Intraoperative blood loss (67.33±19.95mL vs.62.21±15.45mL,P=0.082),postoperative hospital stay (4.65±1.31 days vs.4.31±1.24 days,P=0.237),the incidence of intraoperative high-flow cerebrospinal fluid leakage (4.7% vs.6.1%,P=0.533),intraoperative internal carotid artery injury (0.5% vs.0.6%,P=0.904),and postoperative recovery of pituitary-related hormone levels were not significantly different.The incidence of postoperative complications was low in both groups,and there was no statistical difference between the two groups,including: Postoperative cerebrospinal fluid rhinorrhea (0.9% vs.1.6%,P=0.558),intracranial infection (0.9% vs.1.1%,P=0.865),diabetes insipidus (4.2% vs.6.1%,P=0.533),and rebleeding (0.9% vs.1.1%,P=0.865).Postoperative visual field was significantly improved in both groups,but there was no significant difference in the rate of improvement between the two groups (77.9% vs.85.7%,P=0.170).Conclusion Bothtranssphenoidalneuroendoscopic and microscopic resection of pituitary tumors have satisfactory safety and efficacy.For patients with Knosp III-IV,whose tumors invading the cavernous sinus,neuroendoscopic surgery is more advantageous.

Key words: Neuroendoscope, Microscope, Transsphenoidal, Pituitary tumor

中图分类号:

R736.4

贺虎, 王飞, 凌士营. 经鼻蝶神经内镜与显微镜下切除垂体瘤的安全性与疗效对比[J]. 立体定向和功能性神经外科杂志, 2022, 35(1): 12-17.

He Hu, Wang Fei, Ling Shiying. Comparison of safety and efficacy of transsphenoidal neuroendoscopic and microscopical resection of pituitary tumors[J]. Chinese Journal of Stereotactic and Functional Neurosurgery, 2022, 35(1): 12-17.

参考文献

[1] 陈其钻.垂体腺瘤治疗现状和进展[J].中国临床神经外科杂志,2013,18(6):381~384.
[2] Baker C,Karsy M,Couldwell WT.Resection of pituitary tumor with lateral extension to the temporal fossa::the toothpaste extrusion technique[J].Cureus,2019,11(10):e5953.
[3] Wang AC,Shah AH,Sidani C,et al.Volumetry in the assessment of pituitary adenoma resection: endoscopy versus microscopy[J].J Neurol Surg B Skull Base,2018,79(6):538~544.
[4] Locatelli D,Veiceschi P,Castelnuovo P,et al.Transsph-enoidal surgery for pituitary adenomas in pediatric patientss:a mul~ ticentric retrospective study[J].Childs Nerv Syst,2019,35(11): 2119~2126.
[5] Perry A,Graffeo CS,Meyer J,et al.Beyond the learning curve: comparison of microscopic and endoscopic incidences of internal carotid injury in a series of highly experienced operators[J].World Neurosurg,2019,131:e128~e135.
[6] Khalafallah AM,Liang AL,Jimenez AE,et al.Trends in endoscopic and microscopic transsphenoidal surgery: a survey of the international society of pituitary surgeons between 2010 and 2020[J].Pituitary,2020,23(5):526~533.
[7] 中国垂体腺瘤协作组.中国垂体腺瘤外科治疗专家共识[J].中华医学杂志,2015,95(5):324~329.
[8] Paluzzi A,Fernandez-Miranda JC,Pinheiro-Neto C,et al.Endoscopic endonasal infrasellar approach to the sellar and suprasellar regions: technical note[J].Skull Base,2011,21(5): 335~342.
[9] Paluzzi A,Fernandez~Miranda JC,Tonya Stefko S,Challinor S,Snyderman CH,Gardner PA.Endoscopic endonasal approach for pituitary adenomas: a series of 555 patients[J].Pituitary,2014,17(4):307~319.
[10] Choby GW,Mattos JL,Hughes MA,et al.Delayed nasoseptal flflaps for endoscopic skull base reconstruction: proof of concept and evaluation of outcomes[J].Otolaryngol Head Neck Surg,2015,152(2):255~259.
[11] Little AS,Kelly DF,White WL,et al.Results of a prospective multicenter controlled study comparing surgical outcomes of microscopic versus fully endoscopic transsphenoidal surgery for nonfunctioning pituitary adenomas: the transsphenoidal extent of resection (TRANSSPHER) study[J].J Neurosurg,2020,132(4):1043~ 1053.
[12] Guiot G,Bouche J,Hertzog E,Vourc 'HG,Hardy J.Hypophysectomy by trans~sphenoidal route[J].Ann Radiol,1963,6:187~192.
[13] Singh H,Essayed WI,Cohen~Gadol A,et al.Resection of pituitarytumors:endoscopic versus microscopic[J].J Neurooncol,2016,130(2):309~317.
[14] Carrau RL,Jho HD,Ko Y.Transnasal~transsphenoidal endoscopic surgery of the pituitary gland [J].Laryngoscope,1996,106(7):914~918.
[15] Li QX,Wang WH,Wang XX.Various strategies of trans-phenoidalpseudocapsule-based extracapsular resection in nonin-vasive functionalpituitaryadenomas and their effectiveness and safety[J].Neurol India,2019,67(6):1448~1455.
[16] Almutairi RD,Muskens IS,Cote DJ,et al.Gross total resection of pituitary adenomas after endoscopic vs.microscopic transsphenoidal surgery: a meta- analysis [J].Acta Neurochir (Wien),2018,160(5):1005~1021.
[17] Fang J,Xie S,Li N,et al.Postoperative complications of endoscopic versusmicroscopic transsphenoidal pituitary surgery:a meta-analysis[J].J Coll Physicians Surg Pak,2018,28 (7): 554~559.
[18] Staartjes VE,Serra C,Muscas G,et al.Utility of deep neural networks in predicting gross~total resection after transsphenoidal surgery for pituitary adenoma:a pilot study[J].Neurosurg Focus,2018,45(5):e12.
[19] Ding ZQ,Zhang SF,Wang QH.Neuroendoscopic and microscopic transsphenoidal approach for resection of nonfunctional pituitary adenomas [J].World J Clin Cases,2019,7 ( 13 ): 1591~1598.
[20] Staartjes VE,Serra C,Maldaner N,et al.The Zurich Pitui tary Score predicts utility of intraoperative high~field magnetic resonance imaging in transsphenoidal pituitary adenomasurgery[J].Acta Neurochir (Wien),2019,161(10):2107~2115.
[21] Zhang Z,Wang P,Feng S,et al.Endocrinological outcomes of intraoperative mri~guided endoscopic transsphenoidal surgery for non~functioning pituitary adenoma[J].Turk Neurosurg,2019,29(5):635~642.
[22] Chen X,Huang W,Li H,et al.Comparison of outcomes between endoscopic and microscopic transsphenoidal surgery for the treatment of pituitary adenoma: a meta - analysis [J].Gland Surg,2020,9(6):2162~2174.
[23] Wolf A,Coros A,Bierer J,et al.Quantitative evaluation of vision~related and health~related quality of life after endoscopic transsphenoidal surgery for pituitary adenoma [J].J Neurosurg,2017,127(2):409~416.